CellRapeutics™ Leukopak from Age-related Macular Degeneration Donor (XS-0426-XU224)

Name: CellRapeutics™ Leukopak from Age-related Macular Degeneration Donor
SKU: XS-0426-XU224
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak provides a highly concentrated collection of peripheral blood mononuclear cells from donors diagnosed with Age-related Macular Degeneration. The cellular composition includes systemic myeloid and lymphoid subsets involved in the chronic, low-grade inflammatory processes that contribute to retinal pigment epithelium damage. It serves as an expansive reservoir of primary cells for investigating the systemic innate-immune components of ocular neurodegeneration.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Age-related Macular Degeneration Donor

Cat. No.
XS-0426-XU224

Donor Age
Senior

Donor Health
Donors exhibit a chronic systemic pro-inflammatory state. The leukocyte profile is characterized by alterations in complement-regulating monocytic subsets and signatures associated with advanced age and senescent immune remodeling.

Ethnicity
Predominantly Caucasian.

Anticoagulant
Acid Citrate Dextrose, formulated to stabilize aged immune cell populations and minimize oxidative stress during collection.

Additional Donor Information
Each lot features a Leukopak from donors with dry or wet AMD. Profiles include visual impairment severity and age-matched clinical data to study the systemic myeloid contribution to retinal inflammation.

Clinical Profile
Disease stage and classification.

Additional Information

Medication History
Available upon request. Documentation of AREDS vitamins/supplements and history of anti-VEGF intravitreal injections, confirms absence of systemic immunomodulatory treatments.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Age-related Macular Degeneration Donor, Leukopak, Age-related Macular Degeneration

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Age-related Macular Degeneration Donor (XS-0426-XU224). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.